Anesthesia for Open Pulmonary Resection: A Systems Approach

  • E. Andrew Ochroch
  • Eric Lambright
  • Miklos Kertai
  • Bernard J. C. J. Riedel


Perioperative morbidity and mortality is common following lung resection, with most deaths (>75%) attributed to major adverse pulmonary events (MAPE; including pneumonia, acute lung injury [ALI], and acute respiratory distress syndrome [ARDS]). Perioperative risk can be managed by dividing risk into two broad categories: iatrogenic risk and patient-attributed risk. Clinical care pathways manage iatrogenic risk, while perioperative strategies that allow identification and optimal management of high-risk patients manage patient-attributed risk. These factors will improve outcomes and reduce hospital costs. Patient safety and the delivery of quality care, with emphasis on systems improvement, have emerged as central tasks for healthcare providers. In fact, benchmarking of data will increasingly allow patients to identify institutions that deliver on the value proposition – providing medical care that measures up in safety and quality and yet is delivered at significantly lower costs.


Chronic Obstructive Pulmonary Disease Continuous Positive Airway Pressure Pulmonary Resection Hypoxic Pulmonary Vasoconstriction Anesthesia Information Management System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Dulu A, Pastores SM, Park B, Riedel E, Rusch V, Halpern NA. Prevalence and mortality of acute lung injury and ARDS after lung resection. Chest. 2006;130(1):73–8.PubMedGoogle Scholar
  2. 2.
    Tang SS, Redmond K, Griffiths M, Ladas G, Goldstraw P, Dusmet M. The mortality from acute respiratory distress syndrome after pulmonary resection is reducing: a 10-year single institutional experience. Eur J Cardiothorac Surg. 2008;34(4):898–902.PubMedGoogle Scholar
  3. 3.
    Lighter DE. Advanced performance improvement in healthcare. Sudbury: Jones and Bartlett Publishers; 2010.Google Scholar
  4. 4.
    Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, D.C.: National Academies Press; 2000.Google Scholar
  5. 5.
    Institute of Medicine Committee on Quality Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, D.C.: National Academies Press; March 2008.Google Scholar
  6. 6.
    Vincent C, Moorthy K, Sarker SK, Chang A, Darzi AW. Systems approaches to surgical quality and safety: from concept to measurement. Ann Surg. 2004;239(4):475–82.PubMedGoogle Scholar
  7. 7.
    Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg. 2003;75(2):337–41.PubMedGoogle Scholar
  8. 8.
    Chowdhury MM, Dagash H, Pierro A. A systematic review of the impact of volume of surgery and specialization on patient outcome. Br J Surg. 2007;94(2):145–61.PubMedGoogle Scholar
  9. 9.
    Dimick JB, Cowan Jr JA, Ailawadi G, Wainess RM, Upchurch Jr GR. National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch Surg. 2003;138(12):1305–9.PubMedGoogle Scholar
  10. 10.
    Dimick JB, Cowan Jr JA, Upchurch Jr GR, Colletti LM. Hospital volume and surgical outcomes for elderly patients with colorectal cancer in the United States. J Surg Res. 2003;114(1):50–6.PubMedGoogle Scholar
  11. 11.
    Verhoef C, van de Weyer R, Schaapveld M, Bastiaannet E, Plukker JTM. Better survival in patients with esophageal cancer after surgical treatment in university hospitals: a plea for performance by surgical oncologists. Ann Surg Oncol. 2007;14(5):1678–87.PubMedGoogle Scholar
  12. 12.
    Zehr KJ, Dawson PB, Yang SC, Heitmiller RF. Standardized clinical care pathways for major thoracic cases reduce hospital costs. Ann Thorac Surg. 1998;66(3):914–9.PubMedGoogle Scholar
  13. 13.
    Wright CD, Wain JC, Grillo HC, Moncure AC, Macaluso SM, Mathisen DJ. Pulmonary lobectomy patient care pathway: a model to control cost and maintain quality. Ann Thorac Surg. 1997;64(2):299–302.PubMedGoogle Scholar
  14. 14.
    Khuri SF. Quality, advocacy, healthcare policy, and the surgeon. Ann Thorac Surg. 2002;74(3):641–9.PubMedGoogle Scholar
  15. 15.
    Khuri SF, Daley J, Henderson WG. The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs. Arch Surg. 2002;137(1):20–7.PubMedGoogle Scholar
  16. 16.
    Ries AL, Make BJ, Lee SM, et al. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest. 2005;128(6):3799–809.PubMedGoogle Scholar
  17. 17.
    Ries AL. Pulmonary rehabilitation and COPD. Semin Respir Crit Care Med. 2005;26(2):133–41.PubMedGoogle Scholar
  18. 18.
    Ochroch EA, Gottschalk A, Augostides J, et al. Long-term pain and activity during recovery from major thoracotomy using thoracic epidural analgesia. Anesthesiology. 2002;97(5):1234–44.PubMedGoogle Scholar
  19. 19.
    Devereaux PJ, Yang H, Yusuf S, and the POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371(9627):1839–47.Google Scholar
  20. 20.
    Garcia S, Moritz TE, Ward HB, et al. Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease. Am J Cardiol. 2008;102(7):809–13.PubMedGoogle Scholar
  21. 21.
    Garcia S, McFalls EO. CON: preoperative coronary revascularization in high-risk patients undergoing vascular surgery. Anesth Analg. 2008;106(3):764–6.PubMedGoogle Scholar
  22. 22.
    McFalls EO, Ward HB, Moritz TE, et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial. Eur Heart J. 2008;29(3):394–401.PubMedGoogle Scholar
  23. 23.
    McFalls EO, Ward HB, Moritz TE, et al. Clinical factors associated with long-term mortality following vascular surgery: outcomes from the Coronary Artery Revascularization Prophylaxis (CARP) Trial. J Vasc Surg. 2007;46(4):694–700.PubMedGoogle Scholar
  24. 24.
    McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery.[see comment]. N Engl J Med. 2004;351(27):2795–804.PubMedGoogle Scholar
  25. 25.
    Beattie WS, Wijeysundera DN, Karkouti K, et al. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study. Anesthesiology. 2010;112(1):25–33.PubMedGoogle Scholar
  26. 26.
    Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology. 2006;105(6):1260–72.PubMedGoogle Scholar
  27. 27.
    Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361(10):980–9.PubMedGoogle Scholar
  28. 28.
    Amar D, Zhang H, Heerdt PM, Park B, Fleisher M, Thaler HT. Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein. Chest. 2005;128(5):3421–7.PubMedGoogle Scholar
  29. 29.
    Amar D. Beta-adrenergic blocker withdrawal confounds the benefits of epidural analgesia with sympathectomy on supraventricular arrhythmias after cardiac surgery. Anesth Analg. 2002;95(4):1119, author reply 1119.Google Scholar
  30. 30.
    Schouten O, Hoeks SE, Welten GM, et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol. 2007;100(2):316–20.PubMedGoogle Scholar
  31. 31.
    Anon. Rebound risk: aspirin and statin withdrawal. Consum Rep. 2005;70(8):48.Google Scholar
  32. 32.
    Collet JP, Montalescot G. Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit? Int J Cardiol. 2009;133(1):8–17.PubMedGoogle Scholar
  33. 33.
    Daly DJ, Myles PS. Update on the role of paravertebral blocks for thoracic surgery: are they worth it? Curr Opin Anaesthesiol. 2009;22(1):38–43.PubMedGoogle Scholar
  34. 34.
    Joshi GP, Bonnet F, Shah R, et al. A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia. Anesth Analg. 2008;107(3):1026–40.PubMedGoogle Scholar
  35. 35.
    Conlon NP, Shaw AD, Grichnik KP. Postthoracotomy paravertebral analgesia: will it replace epidural analgesia? Anesthesiol Clin. 2008;26(2):369–80.PubMedGoogle Scholar
  36. 36.
    Samain E, Biard M, Farah E, Holtzer S, Delefosse D, Marty J. Monitoring expired oxygen fraction in preoxygenation of patients with chronic obstructive pulmonary disease. Ann Fr Anesth Rèanim. 2002;21(1):14–9.PubMedGoogle Scholar
  37. 37.
    Servin FS, Billard V. Remifentanil and other opioids. Handb Exp Pharmacol. 2008;182:283–311.PubMedGoogle Scholar
  38. 38.
    Slinger P. Update on anesthetic management for pneumonectomy. Curr Opin Anaesthesiol. 2009;22(1):31–7.PubMedGoogle Scholar
  39. 39.
    Bigatello LM, Allain R, Gaissert HA. Acute lung injury after pulmonary resection. Minerva Anestesiol. 2004;70(4):159–66.PubMedGoogle Scholar
  40. 40.
    Michelet P, D’Journo XB, Roch A, et al. Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study. Anesthesiology. 2006;105(5):911–9.PubMedGoogle Scholar
  41. 41.
    Choi G, Wolthuis EK, Bresser P, et al. Mechanical ventilation with lower tidal volumes and positive end-expiratory pressure prevents alveolar coagulation in patients without lung injury. Anesthesiology. 2006;105(4):689–95.PubMedGoogle Scholar
  42. 42.
    Determann RM, Royakkers A, Wolthuis EK, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care. 2010;14(1):R1.PubMedGoogle Scholar
  43. 43.
    Ward J, McMurtry I. Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. Curr Opin Pharmacol. 2009;9:1–10.Google Scholar
  44. 44.
    Aaronson PI, Robertson TP, Knock GA, et al. Hypoxic pulmonary vasoconstriction: mechanisms and controversies. J Physiol. 2006;570(Pt 1):53–8.PubMedGoogle Scholar
  45. 45.
    Rhodes CJ, Davidson A, Gibbs JSR, Wharton J, Wilkins MR. Therapeutic targets in pulmonary arterial hypertension. Pharmacol Ther. 2009;121(1):69–88.PubMedGoogle Scholar
  46. 46.
    Weigand L, Sylvester JT, Shimoda LA. Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol. 2006;290(2):L284–90.PubMedGoogle Scholar
  47. 47.
    Jernigan NL, Walker BR, Resta TC. Chronic hypoxia augments protein kinase G-mediated Ca2+ desensitization in pulmonary vascular smooth muscle through inhibition of RhoA/Rho kinase signaling. Am J Physiol Lung Cell Mol Physiol. 2004;287(6):L1220–9.PubMedGoogle Scholar
  48. 48.
    Yamamoto Y, Nakano H, Ide H, et al. Role of airway nitric oxide on the regulation of pulmonary circulation by carbon dioxide. J Appl Physiol. 2001;91(3):1121–30.PubMedGoogle Scholar
  49. 49.
    Nagendran J, Stewart K, Hoskinson M, Archer SL. An anesthesiologist’s guide to hypoxic pulmonary vasoconstriction: implications for managing single-lung anesthesia and atelectasis. Curr Opin Anaesthesiol. 2006;19(1):34–43.PubMedGoogle Scholar
  50. 50.
    Abe K, Shimizu T, Takashina M, Shiozaki H, Yoshiya I. The effects of propofol, isoflurane, and sevoflurane on oxygenation and shunt fraction during one-lung ventilation [see comment]. Anesth Analg. 1998;87(5):1164–9.PubMedGoogle Scholar
  51. 51.
    Pruszkowski O, Dalibon N, Moutafis M, et al. Effects of propofol vs sevoflurane on arterial oxygenation during one-lung ventilation. Br J Anaesth. 2007;98(4):539–44.PubMedGoogle Scholar
  52. 52.
    Popping DM, Elia N, Marret E, Remy C, Tramer MR. Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: a meta-analysis. Arch Surg. 2008;143(10):990–9. discussion 1000.PubMedGoogle Scholar
  53. 53.
    Groeben H. Epidural anesthesia and pulmonary function. J Anesth. 2006;20(4):290–9.PubMedGoogle Scholar
  54. 54.
    Moraca RJ, Sheldon DG, Thirlby RC. The role of epidural anesthesia and analgesia in surgical practice [see comment]. Ann Surg. 2003;238(5):663–73.PubMedGoogle Scholar
  55. 55.
    Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002;183(6):630–41.PubMedGoogle Scholar
  56. 56.
    Grass JA. The role of epidural anesthesia and analgesia in postoperative outcome. Anesthesiol Clin N Am. 2000;18(2):407–28.Google Scholar
  57. 57.
    De Cosmo G, Aceto P, Gualtieri E, Congedo E. Analgesia in thoracic surgery: review. Minerva Anestesiol. 2009;75(6):393–400.PubMedGoogle Scholar
  58. 58.
    Guay J. The benefits of adding epidural analgesia to general anesthesia: a metaanalysis. J Anesth. 2006;20(4):335–40.PubMedGoogle Scholar
  59. 59.
    Holte K, Kehlet H. Effect of postoperative epidural analgesia on surgical outcome. Minerva Anestesiol. 2002;68(4):157–61.PubMedGoogle Scholar
  60. 60.
    Lewis KS, Whipple JK, Michael KA, Quebbeman EJ. Effect of analgesic treatment on the physiological consequences of acute pain. Am J Hosp Pharm. 1994;51(12):1539–54.PubMedGoogle Scholar
  61. 61.
    Kehlet H. The stress response to surgery: release mechanisms and the modifying effect of pain relief. Acta Chir Scand Suppl. 1989;550:22–8.PubMedGoogle Scholar
  62. 62.
    Hahnenkamp K, Herroeder S, Hollmann MW. Regional anaesthesia, local anaesthetics and the surgical stress response. Best Pract Res Clin Anaesthesiol. 2004;18(3):509–27.PubMedGoogle Scholar
  63. 63.
    Yeager MP, Glass DD, Neff RK, Brinck-Johnsen T. Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology. 1987;66(6):729–36.PubMedGoogle Scholar
  64. 64.
    Clemente A, Carli F. The physiological effects of thoracic epidural anesthesia and analgesia on the cardiovascular, respiratory and gastrointestinal systems. Minerva Anestesiol. 2008;74(10): 549–63.PubMedGoogle Scholar
  65. 65.
    Bromage P. Spirometery in assessment of analgesia after abdominal surgery. Br Med J. 1955;2:589–93.PubMedGoogle Scholar
  66. 66.
    Spray SB, Zuidema GD, Cameron JL. Aspiration pneumonia; incidence of aspiration with endotracheal tubes. Am J Surg. 1976;131(6):701–3.PubMedGoogle Scholar
  67. 67.
    Sackner MA, Hirsch J, Epstein S. Effect of cuffed endotracheal tubes on tracheal mucous velocity. Chest. 1975;68(6):774–7.PubMedGoogle Scholar
  68. 68.
    Chaney MA. Intrathecal and epidural anesthesia and analgesia for cardiac surgery [see comment]. Anesth Analg. 2006;102(1):45–64.PubMedGoogle Scholar
  69. 69.
    Riedel BJ, Wright IG. Epidural anesthesia in coronary artery bypass grafting surgery. Curr Opin Cardiol. 1997;12(6):515–21.PubMedGoogle Scholar
  70. 70.
    Grape S, Tramer MR. Do we need preemptive analgesia for the treatment of postoperative pain? Best Pract Res Clin Anaesthesiol. 2007;21(1):51–63.PubMedGoogle Scholar
  71. 71.
    Pogatzki-Zahn EM, Zahn PK. From preemptive to preventive analgesia. Curr Opin Anaesthesiol. 2006;19(5):551–5.PubMedGoogle Scholar
  72. 72.
    Gottschalk A, Cohen SP, Yang S, Ochroch EA. Preventing and treating pain after thoracic surgery. Anesthesiology. 2006;104(3):594–600.PubMedGoogle Scholar
  73. 73.
    Ochroch EA, Gottschalk A. Impact of acute pain and its management for thoracic surgical patients. Thorac Surg Clin. 2005;15(1):105–21.PubMedGoogle Scholar
  74. 74.
    George MJ. The site of action of epidurally administered opioids and its relevance to postoperative pain management. Anaesthesia. 2006;61(7):659–64.PubMedGoogle Scholar
  75. 75.
    Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy–a systematic review and meta-analysis of randomized trials.[erratum appears in Br J Anaesth. 2007 Nov;99(5):768]. Br J Anaesth. 2006;96(4):418–26.PubMedGoogle Scholar
  76. 76.
    Chong PC, Greco EF, Stothart D, et al. Substantial variation of both opinions and practice regarding perioperative fluid resuscitation. Can J Surg. 2009;52(3):207–14.PubMedGoogle Scholar
  77. 77.
    Turnage WS, Lunn JJ. Postpneumonectomy pulmonary edema. A retrospective analysis of associated variables [see comment]. Chest. 1993;103(6):1646–50.PubMedGoogle Scholar
  78. 78.
    Jackson TA, Mehran RJ, Thakar D, Riedel B, Nunnally ME, Slinger P. Case 5–2007 postoperative complications after pneumonectomy: clinical conference. J Cardiothorac Vasc Anesth. 2007;21(5):743–51.PubMedGoogle Scholar
  79. 79.
    Jordan S, Mitchell JA, Quinlan GJ, Goldstraw P, Evans TW. The pathogenesis of lung injury following pulmonary resection.[see comment]. Eur Respir J. 2000;15(4):790–9.PubMedGoogle Scholar
  80. 80.
    Polubinska A, Breborowicz A, Staniszewski R, Oreopoulos DG. Normal saline induces oxidative stress in peritoneal mesothelial cells. J Pediatr Surg. 2008;43(10):1821–6.PubMedGoogle Scholar
  81. 81.
    Westphal M, James MFM, Kozek-Langenecker S, Stocker R, Guidet B, Van Aken H. Hydroxyethyl starches: different products–different effects. Anesthesiology. 2009;111(1):187–202.PubMedGoogle Scholar
  82. 82.
    Boldt J. Modern rapidly degradable hydroxyethyl starches: current concepts. Anesth Analg. 2009;108(5):1574–82.PubMedGoogle Scholar
  83. 83.
    Boldt J. Saline versus balanced hydroxyethyl starch: does it matter? Curr Opin Anaesthesiol. 2008;21(5):679–83.PubMedGoogle Scholar
  84. 84.
    Ueda H, Iwasaki A, Kusano T, Shirakusa T. Thoracotomy in patients with liver cirrhosis. Scand J Thorac Cardiovasc Surg. 1994;28(1):37–41.PubMedGoogle Scholar
  85. 85.
    Ceyhan B, Celikel T. Serum-effusion albumin gradient in separation of transudative and exudative pleural effusions [comment]. Chest. 1994;105(3):974–5.PubMedGoogle Scholar
  86. 86.
    Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly. Chest. 1999;116(2):355–62.PubMedGoogle Scholar
  87. 87.
    Jordan S, Evans TW. Predicting the need for intensive care following lung resection. Thorac Surg Clin. 2008;18(1):61–9.PubMedGoogle Scholar
  88. 88.
    Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005;40(2):90–7.PubMedGoogle Scholar
  89. 89.
    Maggiore C, Mule A, Fadda G, et al. Histological classification of lung cancer. Rays Oct Dec. 2004;29(4):353–5.Google Scholar
  90. 90.
    Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest. 2003;123(1 Suppl):97S–104.PubMedGoogle Scholar
  91. 91.
    Radulescu D, Pripon S, Bunea D, Ciuleanu TE, Radulescu LI. Endocrine paraneoplastic syndromes in small cell lung carcinoma. Two case reports. J BUON. 2007;12(3):411–4.PubMedGoogle Scholar
  92. 92.
    Gandhi L, Johnson BE. Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Cancer Netw. 2006;4(6):631–8.Google Scholar
  93. 93.
    Gerber RB, Mazzone P, Arroliga AC. Paraneoplastic syndromes associated with bronchogenic carcinoma. Clin Chest Med. 2002;23(1):257–64.PubMedGoogle Scholar
  94. 94.
    Posner JB, Dalmau J. Paraneoplastic syndromes. Curr Opin Immunol. 1997;9(5):723–9.PubMedGoogle Scholar
  95. 95.
    Amer KM, Ibrahim NB, Forrester-Wood CP, Saad RA, Scanlon M. Lung carcinoid related Cushing’s syndrome: report of three cases and review of the literature. Postgrad Med J. 2001; 77(909):464–7.PubMedGoogle Scholar
  96. 96.
    Pourmand R. Lambert-eaton myasthenic syndrome. Front Neurol Neurosci. 2009;26:120–5.PubMedGoogle Scholar
  97. 97.
    Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol. 2006;33(3):270–98.PubMedGoogle Scholar
  98. 98.
    Endo C, Sagawa M, Sakurada A, Sato M, Kondo T, Fujimura S. Surgical treatment of stage I non-small cell lung carcinoma. Ann Thorac Cardiovasc Surg. 2003;9(5):283–9.PubMedGoogle Scholar
  99. 99.
    Fenwick JD, Nahum AE, Malik ZI, et al. Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement. Clin Oncol. 2009;21(4):343–60.Google Scholar
  100. 100.
    Ikeda N, Nagase S, Ohira T. Individualized adjuvant chemotherapy for surgically resected lung cancer and the roles of biomarkers. Ann Thorac Cardiovasc Surg. 2009;15(3):144–9.PubMedGoogle Scholar
  101. 101.
    Custodio AB, Gonzalez-Larriba JL, Bobokova J, et al. Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer. J Thorac Oncol. 2009;4(7):891–910.PubMedGoogle Scholar
  102. 102.
    John T, Liu G, Tsao MS. Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors. Oncogene. 2009;28 Suppl 1:S14–23.PubMedGoogle Scholar
  103. 103.
    Goldfarb Y, Ben-Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Dis. 2006;26:99–114.PubMedGoogle Scholar
  104. 104.
    Ben-Eliyahu S, Page GG, Schleifer SJ. Stress, NK cells, and cancer: Still a promissory note. Brain Behav Immun. 2007;21(7):881–7.PubMedGoogle Scholar
  105. 105.
    Atzil S, Arad M, Glasner A, et al. Blood transfusion promotes cancer progression: a critical role for aged erythrocytes. Anesthesiology. 2008;109(6):989–97.PubMedGoogle Scholar
  106. 106.
    Sessler DI, Ben-Eliyahu S, Mascha EJ, Parat MO, Buggy DJ. Can regional analgesia reduce the risk of recurrence after breast cancer? Methodology of a multicenter randomized trial. Contemp Clin Trials. 2008;29(4):517–26.PubMedGoogle Scholar
  107. 107.
    Chan KK, Oza AM, Siu LL. The statins as anticancer agents. Clin Cancer Res. 2003;9(1):10–9.PubMedGoogle Scholar
  108. 108.
    Demierre MF, Higgins PD, Gruber SB, Hawk E, Lippman SM. Statins and cancer prevention. Nat Rev Cancer. 2005;5(12):930–42.PubMedGoogle Scholar
  109. 109.
    Ogunwobi OO, Beales IL. Statins inhibit proliferation and induce apoptosis in Barrett’s esophageal adenocarcinoma cells. Am J Gastroenterol. 2008;103(4):825–37.PubMedGoogle Scholar
  110. 110.
    Maksimova E, Yie TA, Rom WN. In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent. Lung. 2008;186(1):45–54.PubMedGoogle Scholar
  111. 111.
    Khurana V, Bejjanki HR, Caldito G, Owens MW. Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans. Chest. 2007;131(5):1282–8.PubMedGoogle Scholar
  112. 112.
    Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28:1467–72.PubMedGoogle Scholar
  113. 113.
    Norman PH, Thall PF, Purugganan RV, et al. A possible association between aprotinin and improved survival after radical surgery for mesothelioma. Cancer. 2009;115(4):833–41.PubMedGoogle Scholar
  114. 114.
    Norman P. Rofecoxib provides significant improvement in survival following lung resection for cancer. Anesthesiology. 2008;109:A1586.Google Scholar
  115. 115.
    Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105(4):660–4.PubMedGoogle Scholar
  116. 116.
    Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology. 2007;106(3):499–506.PubMedGoogle Scholar
  117. 117.
    Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology. 2008;109(2):180–7.PubMedGoogle Scholar
  118. 118.
    American Thoracic Society Guidelines for patient undergoing possible pulmonary resection    Accessed May 2010.
  119. 119.
    Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81(3):1013–9. discussion 1019–1020.PubMedGoogle Scholar
  120. 120.
    Whitson BA, Groth SS, Duval SJ, Swanson SJ, Maddaus MA. Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy. Ann Thorac Surg. 2008;86(6):2008–16. discussion 2016–2008.PubMedGoogle Scholar
  121. 121.
    Mahtabifard A, DeArmond DT, Fuller CB, McKenna Jr RJ. Video-assisted thoracoscopic surgery lobectomy for stage I lung cancer. Thorac Surg Clin. 2007;17(2):223–31.PubMedGoogle Scholar
  122. 122.
    Lytle FT, Brown DR. Appropriate ventilatory settings for thoracic surgery: intraoperative and postoperative. Semin Cardiothorac Vasc Anesth. 2008;12(2):97–108.PubMedGoogle Scholar
  123. 123.
    Licker M, Fauconnet P, Villiger Y, Tschopp JM. Acute lung injury and outcomes after thoracic surgery. Curr Opin Anaesthesiol. 2009;22(1):61–7.PubMedGoogle Scholar
  124. 124.
    Prokakis C, Koletsis EN, Apostolakis E, et al. Routine suction of intercostal drains is not necessary after lobectomy: a prospective randomized trial. World J Surg. 2008;32(11):2336–42.PubMedGoogle Scholar
  125. 125.
    Bagan P, Berna P, Pereira JCDN, et al. Sleeve lobectomy versus pneumonectomy: tumor characteristics and comparative analysis of feasibility and results. Ann Thorac Surg. 2005;80(6):2046–50.PubMedGoogle Scholar
  126. 126.
    Ramnath N, Demmy TL, Antun A, et al. Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting survival. Ann Thorac Surg. 2007;83(5):1831–6.PubMedGoogle Scholar
  127. 127.
    Zeldin RA, Normandin D, Landtwing D, Peters RM. Postpneumonectomy pulmonary edema. J Thorac Cardiovasc Surg. 1984;87(3):359–65.PubMedGoogle Scholar
  128. 128.
    Licker M, de Perrot M, Spiliopoulos A, et al. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg. 2003;97(6):1558–65.PubMedGoogle Scholar
  129. 129.
    Foroulis CN, Kotoulas CS, Kakouros S, et al. Study on the late effect of pneumonectomy on right heart pressures using Doppler echocardiography. Eur J Cardio Thorac Surgery. 2004;26(3):508–14.Google Scholar
  130. 130.
    Fernandez-Perez ER, Keegan MT, Brown DR, Hubmayr RD, Gajic O. Intraoperative tidal volume as a risk factor for respiratory failure after pneumonectomy. Anesthesiology. 2006;105(1):14–8.PubMedGoogle Scholar
  131. 131.
    Schilling T, Kozian A, Huth C, et al. The pulmonary immune effects of mechanical ventilation in patients undergoing thoracic surgery. Anesth Analg. 2005;101(4):957–65.PubMedGoogle Scholar
  132. 132.
    Cerfolio RJ, Allen MS, Trastek VF, Deschamps C, Scanlon PD, Pairolero PC. Lung resection in patients with compromised pulmonary function. Ann Thorac Surg. 1996;62(2):348–51.PubMedGoogle Scholar
  133. 133.
    McGlade DP, Slinger PD. The elective combined use of a double lumen tube and endobronchial blocker to provide selective lobar isolation for lung resection following contralateral lobectomy. Anesthesiology. 2003;99(4):1021–2.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • E. Andrew Ochroch
    • 1
  • Eric Lambright
    • 2
  • Miklos Kertai
    • 3
  • Bernard J. C. J. Riedel
    • 4
  1. 1.Department of Anesthesiology and Critical CareUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of Thoracic SurgeryVanderbilt University Medical CenterNashvilleUSA
  3. 3.Semmelweis UniversityBudapestHungary
  4. 4.Department of AnesthesiologyVanderbilt University Medical CenterNashvilleUSA

Personalised recommendations